XYZ Pharmaceuticals is considering the acquisition of a smaller biotech firm, Biogen Inc. The acquisition will require an initial investment of $300 million and is expected to generate cash flows of $50 million per year for the next 10 years. Conduct a comprehensive financial analysis of the proposed acquisition, including calculations of the internal rate of return (IRR), net present value (NPV), and payback period.